Search - tctmd.com

Displaying 181 - 200 of 1481

Sort: Relevancy | Date

News Industry News

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

September 15, 2016

News Daily News

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Yael L. Maxwell

September 14, 2016

News Daily News

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Yael L. Maxwell

September 14, 2016

News Opinion Editor's Corner ESC 2016

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Shelley Wood

September 08, 2016

News Industry News

InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias

August 31, 2016

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

Presentation ESC 2016

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

Presenter: Ik-Kyung Jang

August 30, 2016

News Conference News ESC 2016

DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS

Shelley Wood

August 30, 2016

Presentation ESC 2016

DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting?

Presenter: Nicolas Meneveau

August 29, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Global Recall for Certain Lotus Valve Systems Following Reports of Death, Catastrophic Vessel Trauma

Michael H. Wilson

August 03, 2016

News Daily News

Absorb BVS 的 18 个月结果“令人安心”，但仍需要更长期的随访

Michael O'Riordan

August 01, 2016

News Daily News

“Tranquilizadores” Resultados a 18 Meses con el AVB Absorb Aunque Todavía Necesitamos Seguimientos Más Largos

Michael O'Riordan

August 01, 2016

News Daily News

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

Shelley Wood

July 27, 2016

News Daily News

FDA: Angiographic Catheter Recalled Due to Potential Tip Separation

Todd Neale

July 22, 2016

News Daily News

FDA: No More Chances for Embattled Coagulation Monitoring System

Todd Neale

July 13, 2016

News Daily News

FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación

Todd Neale

July 13, 2016

News Daily News

Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print

Yael L. Maxwell

July 12, 2016

Advertisement

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS

DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting?

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

The Bioresorbable Stent Story So Far: What Promise? What Price?

Global Recall for Certain Lotus Valve Systems Following Reports of Death, Catastrophic Vessel Trauma

Absorb BVS 的 18 个月结果“令人安心”，但仍需要更长期的随访

“Tranquilizadores” Resultados a 18 Meses con el AVB Absorb Aunque Todavía Necesitamos Seguimientos Más Largos

New PFO Guidelines: No Routine Offer of Closure for Cryptogenic Stroke, Says American Academy of Neurology

FDA: Angiographic Catheter Recalled Due to Potential Tip Separation

FDA: No More Chances for Embattled Coagulation Monitoring System

FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación

Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content